CSF1R
Colony stimulating factor 1 receptor | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | ? | ||||||
NCBI gene | 1436 | ||||||
HGNC | 2432 | ||||||
OMIM | 164770 | ||||||
RefSeq | NM_005211 | ||||||
UniProt | P07333 | ||||||
|
Colony stimulating factor 1 receptor (CSF1R) is a protein that in humans is encoded by the CSF1R gene. This receptor is a member of the tyrosine kinase family of receptors and plays a crucial role in the regulation of macrophage production, differentiation, and function.
Structure[edit | edit source]
CSF1R is a transmembrane receptor that consists of an extracellular domain, a single transmembrane helix, and an intracellular tyrosine kinase domain. The extracellular domain is responsible for binding its ligand, colony stimulating factor 1 (CSF1), also known as macrophage colony-stimulating factor (M-CSF), and interleukin 34 (IL-34).
Function[edit | edit source]
CSF1R is primarily expressed on the surface of monocytes, macrophages, and their precursors. Upon binding to its ligands, CSF1R undergoes dimerization and autophosphorylation, which activates its kinase activity. This activation triggers a cascade of downstream signaling pathways, including the PI3K/AKT and MAPK/ERK pathways, which are involved in cell survival, proliferation, and differentiation.
Role in Disease[edit | edit source]
Mutations in the CSF1R gene have been associated with several diseases. Notably, hereditary diffuse leukoencephalopathy with spheroids (HDLS) is a rare neurodegenerative disorder caused by mutations in CSF1R. This condition is characterized by white matter degeneration and the presence of axonal spheroids.
CSF1R is also implicated in various cancers, as its overexpression can lead to increased macrophage infiltration and tumor progression. Targeting CSF1R with specific inhibitors is being explored as a therapeutic strategy in cancer treatment.
Clinical Significance[edit | edit source]
CSF1R inhibitors are being developed and tested in clinical trials for their potential to treat cancers and inflammatory diseases. These inhibitors aim to modulate the tumor microenvironment by reducing the number of tumor-associated macrophages, which can promote tumor growth and metastasis.
Research Directions[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which CSF1R signaling influences immune cell behavior and its role in various pathological conditions. The development of more selective and potent CSF1R inhibitors is also a key area of interest.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD